Saturn V Capital Exits Ocular Therapeutix Position Worth $14 Million
On May 15, 2026, Saturn V Capital Management disclosed a full exit from its position in Ocular Therapeutix (NASDAQ:OCUL), selling all 1.5 million shares for an estimated $14.34 million based on quarterly average pricing. The move reflects the fund's strategic shift away from OCUL as it reallocates capital to other holdings.
Tickers: $OCUL
Topics: Ocular Therapeutix Saturn V Capital Management SEC filing stock_exit